153 related articles for article (PubMed ID: 23659599)
41. Study of hTERT and Histone 3 Mutations in Medulloblastoma.
Viana-Pereira M; Almeida GC; Stavale JN; Malheiro S; Clara C; Lobo P; Pimentel J; Reis RM
Pathobiology; 2017; 84(2):108-113. PubMed ID: 27694758
[TBL] [Abstract][Full Text] [Related]
42. Review of the prognostic factors in medulloblastoma of children and adults.
Brandes AA; Paris MK
Crit Rev Oncol Hematol; 2004 May; 50(2):121-8. PubMed ID: 15157661
[TBL] [Abstract][Full Text] [Related]
43. High expression of somatostatin receptor subtype 2 (sst2) in medulloblastoma: implications for diagnosis and therapy.
Frühwald MC; O'Dorisio MS; Pietsch T; Reubi JC
Pediatr Res; 1999 May; 45(5 Pt 1):697-708. PubMed ID: 10231868
[TBL] [Abstract][Full Text] [Related]
44. A novel finding of an IDH2 mutation in an interesting adult Sonic Hedgehog mutated medulloblastoma.
Fomchenko EI; Erson-Omay EZ; Moliterno J
J Neurooncol; 2019 Aug; 144(1):231-233. PubMed ID: 31187320
[No Abstract] [Full Text] [Related]
45. Overexpressed TP73 induces apoptosis in medulloblastoma.
Castellino RC; De Bortoli M; Lin LL; Skapura DG; Rajan JA; Adesina AM; Perlaky L; Irwin MS; Kim JY
BMC Cancer; 2007 Jul; 7():127. PubMed ID: 17626635
[TBL] [Abstract][Full Text] [Related]
46. Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia.
Eberhart CG; Kratz J; Wang Y; Summers K; Stearns D; Cohen K; Dang CV; Burger PC
J Neuropathol Exp Neurol; 2004 May; 63(5):441-9. PubMed ID: 15198123
[TBL] [Abstract][Full Text] [Related]
47. Medulloblastoma with extensive nodularity: a report of two cases.
Hellbusch LC; Robinson MN; McComb RD; Gordon BG; Meyer RC
Pediatr Neurosurg; 2008; 44(5):430-2. PubMed ID: 18703894
[No Abstract] [Full Text] [Related]
48. High expression of DNA methyltransferases in primary human medulloblastoma.
Pócza T; Krenács T; Turányi E; Csáthy J; Jakab Z; Hauser P
Folia Neuropathol; 2016; 54(2):105-13. PubMed ID: 27543768
[TBL] [Abstract][Full Text] [Related]
49. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC
Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813
[TBL] [Abstract][Full Text] [Related]
50. Mini-symposium in medulloblastoma genomics in the modern molecular era.
Ellison DW
Brain Pathol; 2020 May; 30(3):661-663. PubMed ID: 32243002
[No Abstract] [Full Text] [Related]
51. Cytogenetic abnormalities in a disseminated medulloblastoma.
Stuart AG; Pearson AD; Emslie J; Lennard A; Davison EV; Perry RH; Crawford PJ
Med Pediatr Oncol; 1993; 21(4):295-8. PubMed ID: 8469226
[TBL] [Abstract][Full Text] [Related]
52. Medulloblastoma: recent advances and directions in diagnosis and management--Part I.
Chin HW; Maruyama Y; Young AB
Curr Probl Cancer; 1984 May; 8(11):4-54. PubMed ID: 6383718
[No Abstract] [Full Text] [Related]
53. Extra-Axial Cerebellopontine Angle Medulloblastoma in an Infant.
Bhaskar MK; Jaiswal M; Ojha BK; Singh SK; Chandra A; Meel M; Faheem M
Pediatr Neurosurg; 2017; 52(2):122-126. PubMed ID: 28192784
[TBL] [Abstract][Full Text] [Related]
54. Reproducibility of the NanoString 22-gene molecular subgroup assay for improved prognostic prediction of medulloblastoma.
Leal LF; Evangelista AF; de Paula FE; Caravina Almeida G; Carloni AC; Saggioro F; Stavale JN; Malheiros SMF; Mançano B; de Oliveira MA; Luu B; Neder L; Taylor MD; Reis RM
Neuropathology; 2018 Oct; 38(5):475-483. PubMed ID: 30155928
[TBL] [Abstract][Full Text] [Related]
55. Current therapy and new perspectives in the treatment of medulloblastoma.
Whelan HT; Krouwer HG; Schmidt MH; Reichert KW; Kovnar EH
Pediatr Neurol; 1998 Feb; 18(2):103-15. PubMed ID: 9535295
[TBL] [Abstract][Full Text] [Related]
56. Cerebellopontine angle medulloblastoma.
Nyanaveelan M; Azmi A; Saffari M; Banu SK; Suryati MY; Jeyaledchumy M
Med J Malaysia; 2007 Jun; 62(2):173-4. PubMed ID: 18705459
[TBL] [Abstract][Full Text] [Related]
57. MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastoma.
Ryan SL; Schwalbe EC; Cole M; Lu Y; Lusher ME; Megahed H; O'Toole K; Nicholson SL; Bognar L; Garami M; Hauser P; Korshunov A; Pfister SM; Williamson D; Taylor RE; Ellison DW; Bailey S; Clifford SC
Acta Neuropathol; 2012 Apr; 123(4):501-13. PubMed ID: 22139329
[TBL] [Abstract][Full Text] [Related]
58. Spinal metastasis of medulloblastoma in adults.
Menzilcioglu MS; Citil S; Avcu S
Spine J; 2015 Oct; 15(10):e1-2. PubMed ID: 25982440
[No Abstract] [Full Text] [Related]
59. Gorlin syndrome and desmoplastic medulloblastoma: Report of 3 cases with unfavorable clinical course and novel mutations.
Gururangan S; Robinson G; Ellison DW; Wu G; He X; Lu QR; McLendon R; Grant G; Driscoll T; Neuberg R
Pediatr Blood Cancer; 2015 Oct; 62(10):1855-8. PubMed ID: 25940061
[TBL] [Abstract][Full Text] [Related]
60. A case report of a novel germline GNAS mutation in sonic hedgehog activated medulloblastoma.
Crane JN; Chang VY; Yong WH; Salamon N; ; Kianmahd J; Dorrani N; Martinez-Agosto JA; Davidson TB
Pediatr Blood Cancer; 2020 Mar; 67(3):e28103. PubMed ID: 31793173
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
